Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sepsis

Free Subscription Articles published in AIDS Retrieve available abstracts of 36 articles: HTML format

Single Articles

December 2023
1. DORWARD J, Govender K, Moodley P, Lessells R, et al
   Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy.
   AIDS. 2023 Dec 19. doi: 10.1097/QAD.0000000000003818.
   PubMed     Abstract available
   
   
   October 2023
2. LARTEY M, Ganu VJ, Tachi K, Yang H, et al
   Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and HBV viral suppression.
   AIDS. 2023 Oct 20. doi: 10.1097/QAD.0000000000003764.
   PubMed     Abstract available
   
   
   September 2023
3. RACCAGNI AR, Diotallevi S, Lolatto R, Lucente MF, et al
   Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV.
   AIDS. 2023 Sep 29. doi: 10.1097/QAD.0000000000003733.
   PubMed     Abstract available
   
   
   July 2023
4. CHUN HM, Milligan K, Boyd MA, Abutu A, et al
   Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off.
   AIDS. 2023 Jul 28. doi: 10.1097/QAD.0000000000003672.
   PubMed     Abstract available
   
   
   June 2023
5. LEES EA, Tickner N, Lyall H, Mcmaster P, et al
   Infant postnatal prophylaxis following maternal viraemia during breastfeeding.
   AIDS. 2023;37:1185-1186.
   PubMed    
   
   
   February 2023
6. CHAISSON LH, Semitala FC, Nangobi F, Steinmetz S, et al
   Viral suppression among adults with HIV receiving routine dolutegravir-based antiretroviral therapy and 3HP.
   AIDS. 2023 Feb 8. doi: 10.1097/QAD.0000000000003508.
   PubMed     Abstract available
   
   
   January 2023
7. BOWMAN C, Ambrose A, Kanitkar T, Flores K, et al
   Real world use of dolutegravir two drug regimens.
   AIDS. 2023 Jan 16. doi: 10.1097/QAD.0000000000003480.
   PubMed     Abstract available
   
   
   November 2022
8. VAN ZYL G, Jennings L, Kellermann T, Nkantsu Z, et al
   Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.
   AIDS. 2022;36:2057-2062.
   PubMed     Abstract available
   
   
   October 2022
9. CUMMINGS MJ, Bakamutumaho B, Price A, Owor N, et al
   HIV infection drives pro-inflammatory immunothrombotic pathway activation and organ dysfunction among adults with sepsis in Uganda: a prospective cohort study.
   AIDS. 2022 Oct 24. pii: 00002030-990000000-00130.
   PubMed     Abstract available
   
   
   July 2022
10. GIANSERRA L, Dona MG, Giuliani E, Stingone C, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:1319-1320.
    PubMed    
    
    
    June 2022
11. ROUZINE IM
    A role for CD4 helper cells in HIV control and progression.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00045.
    PubMed     Abstract available
    
    
    
12. ELVSTAM O, Marrone G, Engstrom G, Nilsson PM, et al
    Associations between HIV viremia during antiretroviral therapy and cardiovascular disease.
    AIDS. 2022 Jun 23. pii: 00002030-990000000-00036.
    PubMed     Abstract available
    
    
    April 2022
13. LEVI LI, Sharma S, Schleiss MR, Furrer H, et al
    Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy.
    AIDS. 2022 Apr 20. pii: 00002030-990000000-00007.
    PubMed     Abstract available
    
    
    
14. JOSEPH J, Boeke CE, Makadzange EE, Sithole K, et al
    Near-point-of-care viral load testing during pregnancy and viremia at delivery.
    AIDS. 2022;36:711-719.
    PubMed     Abstract available
    
    
    March 2022
15. XU X, Vesterbacka J, Aleman S, Nowak P, et al
    High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV - but HIV viremia matters?
    AIDS. 2022;36:479-481.
    PubMed     Abstract available
    
    
    February 2022
16. JENNINGS L, Robbins RN, Nguyen N, Ferraris C, et al
    Tenofovir diphosphate in dried blood spots predicts future viremia in persons with HIV taking antiretroviral therapy in south africa.
    AIDS. 2022 Feb 8. pii: 00002030-900000000-96225.
    PubMed     Abstract available
    
    
    January 2022
17. ISFORDINK CJ, Smit C, Boyd A, de Regt MJA, et al
    Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands.
    AIDS. 2022 Jan 6. pii: 00002030-900000000-96245.
    PubMed     Abstract available
    
    
    December 2021
18. SCHNEIDER JA, Hayford C, Hotton A, Tabidze I, et al
    Do partner services linked to molecular clusters yield people with viremia or new HIV? results from a historical cohort study.
    AIDS. 2021 Dec 6. pii: 00002030-900000000-96257.
    PubMed     Abstract available
    
    
    November 2021
19. SILVEIRA ELV, Hong JJ, Amancha PK, Rogers KA, et al
    Viremia controls Env-specific antibody-secreting cell responses in simian immunodeficiency virus infected macaques pre and post-antiretroviral therapy.
    AIDS. 2021;35:2085-2094.
    PubMed     Abstract available
    
    
    September 2021
20. VIEIRA VA, Millar J, Adland E, Muenchhoff M, et al
    Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish the rare phenotype of elite control in adolescents living with HIV from viraemic non-progressors.
    AIDS. 2021 Sep 27. pii: 00002030-900000000-96308.
    PubMed     Abstract available
    
    
    August 2021
21. PRENDERGAST AJ, Szubert AJ, Pimundu G, Berejena C, et al
    The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.
    AIDS. 2021;35:1537-1548.
    PubMed     Abstract available
    
    
    June 2021
22. MORROW M, Mawhinney S, Coyle RP, Coleman SS, et al
    Emtricitabine triphosphate in dried blood spots predicts future viremia in persons with HIV and identifies mismatch with self-reported adherence.
    AIDS. 2021 Jun 14. pii: 00002030-900000000-96372.
    PubMed     Abstract available
    
    
    April 2021
23. GIANOTTI N, Galli L, Poli A, Torre LD, et al
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS. 2021 Apr 6. pii: 00002030-900000000-96432.
    PubMed     Abstract available
    
    
    
24. FEINSTEIN MJ, Haberlen SA, Ashikaga H, Palella FJ, et al
    Ventricular ectopy and arrhythmia by HIV serostatus, viremia, and CD4+ cell count.
    AIDS. 2021;35:846-849.
    PubMed    
    
    
    March 2021
25. KAPETANOVIC S, Giganti MJ, Abzug MJ, Lindsey JC, et al
    Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
    AIDS. 2021 Mar 11. pii: 00002030-900000000-96463.
    PubMed     Abstract available
    
    
    
26. RIOS A
    Kaposi sarcoma: a fresh look.
    AIDS. 2021;35:515-516.
    PubMed    
    
    
    November 2020
27. GARCIA M, Morcilla V, Navarrete-Munoz MA, Fisher K, et al
    HIV-DNA Content in pTfh Cells is Associated with Residual Viremia in Elite Controllers.
    AIDS. 2020 Nov 25. doi: 10.1097/QAD.0000000000002776.
    PubMed     Abstract available
    
    
    
28. SEVERIN D, Faiza B, Nadia M, Aurelie DT, et al
    Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.
    AIDS. 2020 Nov 11. doi: 10.1097/QAD.0000000000002744.
    PubMed     Abstract available
    
    
    September 2020
29. CHRISTOPOULOS KA, Neilands TB, Dilworth S, Lisha N, et al
    Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and antiretroviral therapy adherence.
    AIDS. 2020;34:1665-1671.
    PubMed     Abstract available
    
    
    August 2020
30. INZAULE SC, Bertagnolio S, Kityo CM, Siwale M, et al
    The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
    AIDS. 2020;34:1559-1566.
    PubMed     Abstract available
    
    
    
31. LESKO CR, Chander G, Moore RD, Lau B, et al
    Variation in estimated viral suppression associated with the definition of viral suppression used.
    AIDS. 2020;34:1519-1526.
    PubMed     Abstract available
    
    
    February 2020
32. MCCAUSLAND MR, Lebron AC, Pilch-Cooper HA, Howell S, et al
    Toll-like receptor distribution in colonic epithelium and lamina propria is disrupted in HIV viremic, immune success and failure.
    AIDS. 2020 Feb 5. doi: 10.1097/QAD.0000000000002499.
    PubMed     Abstract available
    
    
    September 2019
33. NELSON JAE, de Paris K, Ramirez C, Edmonds A, et al
    Female genital tract shedding of HIV-1 is rare in women with suppressed HIV-1 in plasma.
    AIDS. 2019 Sep 2. doi: 10.1097/QAD.0000000000002373.
    PubMed     Abstract available
    
    
    August 2019
34. REQUENA S, Caballero E, Lozano AB, Rios-Villegas MJ, et al
    Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    AIDS. 2019 Aug 1. doi: 10.1097/QAD.0000000000002338.
    PubMed     Abstract available
    
    
    July 2019
35. FLEMING J, Mathews WC, Rutstein RM, Aberg J, et al
    Low level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002306.
    PubMed     Abstract available
    
    
    
36. DELL'ACQUA R, Galli L, Poli A, Mastrangelo A, et al
    Viro-immunological outcomes after thirteen-valent pneumococcal vaccination in HIV-1 infected subjects on stable virological suppression.
    AIDS. 2019 Jul 10. doi: 10.1097/QAD.0000000000002307.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge.